iRadimed
IRMD
54 hedge funds and large institutions have $54.7M invested in iRadimed in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 11 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 20
0.13% more ownership
Funds ownership: 23.85% → 23.99% (+0.13%)
16% less funds holding
Funds holding: 64 → 54 (-10)
26% less capital invested
Capital invested by funds: $73.7M → $54.7M (-$19M)
82% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$1.55M |
| 2 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
+$1.5M |
| 3 |
BlackRock
New York
|
+$1.16M |
| 4 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
+$959K |
| 5 |
Renaissance Technologies
New York
|
+$405K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$1.77M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$682K |
| 3 |
SIM
Spark Investment Management
New York
|
-$490K |
| 4 |
JP Morgan Chase
New York
|
-$479K |
| 5 |
DCM
Dupont Capital Management
Wilmington,
Delaware
|
-$418K |
IRMD Hedge Fund Activity: Q2 2019 in Review
54 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2019, worth a combined $54.7M — down 26% from $73.7M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of IRMD and 2 opened new positions — a net loss of 9 holders — while 20 trimmed existing stakes and 24 added.
The largest buyer was Marshall Wace, adding an estimated $1.55M. The largest seller was Russell Investments Group, exiting entirely with an estimated $1.77M sold.
- 54 institutional investors held iRadimed (IRMD) as of Q2 2019, down from 64 in Q1 2019.
- Funds reported $54.7M of iRadimed stock for Q2 2019, down 26% quarter-over-quarter.
- 2 funds opened new iRadimed positions in Q2 2019 and 11 closed out, a net change of -9 holders.
- The largest iRadimed buyer in Q2 2019 was Marshall Wace, an estimated $1.55M added.
- The largest iRadimed seller in Q2 2019 was Russell Investments Group, an estimated $1.77M sold.
Based on aggregated 13F filings for Q2 2019.